Risk of gastrointestinal effects with COX-2 inhibitors and NSAIDs: COX-2 inhibitors were thought of as a safe option.
作者信息
Lewis Michael R, Kay Diana
出版信息
BMJ. 2005 Dec 17;331(7530):1474. doi: 10.1136/bmj.331.7530.1474-b.
Abstract
摘要
相似文献
1
Risk of gastrointestinal effects with COX-2 inhibitors and NSAIDs: COX-2 inhibitors were thought of as a safe option.COX-2抑制剂和非甾体抗炎药引起胃肠道不良反应的风险：COX-2抑制剂曾被认为是一种安全的选择。
BMJ. 2005 Dec 17;331(7530):1474. doi: 10.1136/bmj.331.7530.1474-b.
2
Risk of gastrointestinal effects with COX-2 inhibitors and NSAIDs: why were patients at major risk excluded?COX-2抑制剂和非甾体抗炎药引起胃肠道不良反应的风险：为何将高风险患者排除在外？
BMJ. 2005 Dec 17;331(7530):1474. doi: 10.1136/bmj.331.7530.1474-a.
3
Risk of gastrointestinal effects with COX-2 inhibitors and NSAIDs: what does evidence from randomised trials show about celecoxib?
BMJ. 2005 Dec 17;331(7530):1474-5. doi: 10.1136/bmj.331.7530.1474-c.
4
Risk of gastrointestinal effects with COX-2 inhibitors and NSAIDs: how strong is the evidence?COX-2抑制剂和非甾体抗炎药引发胃肠道不良反应的风险：证据有多确凿？
BMJ. 2005 Dec 17;331(7530):1474. doi: 10.1136/bmj.331.7530.1474.
5
Risk of gastrointestinal effects with COX-2 inhibitors and NSAIDs: study conclusions do not reflect findings for celecoxib.COX-2抑制剂和非甾体抗炎药引起胃肠道不良反应的风险：研究结论未反映塞来昔布的研究结果。
BMJ. 2005 Dec 17;331(7530):1473-4. doi: 10.1136/bmj.331.7530.1473-d.
6
Upper gastrointestinal complications: the causes, consequences, and clinical outcomes.上消化道并发症：病因、后果及临床结局
Am J Manag Care. 2001 Sep;7(12 Suppl):S397-401.
7
Gastrointestinal bleeding after the introduction of COX 2 inhibitors: ecological study.引入COX-2抑制剂后发生的胃肠道出血：生态学研究
BMJ. 2004 Jun 12;328(7453):1415-6. doi: 10.1136/bmj.38068.716262.F7. Epub 2004 May 11.
8
Risk of upper gastrointestinal hemorrhage in warfarin users treated with nonselective NSAIDs or COX-2 inhibitors.接受非选择性非甾体抗炎药或COX-2抑制剂治疗的华法林使用者发生上消化道出血的风险。
Arch Intern Med. 2005 Jan 24;165(2):189-92. doi: 10.1001/archinte.165.2.189.
9
Coxibs and NSAIDs: a chronology of confusion.昔布类药物与非甾体抗炎药：混乱的年表
J Pain Palliat Care Pharmacother. 2006;20(4):5-7.
10
COX-2 inhibitors and Celebrex: safe or suspect?
Health News. 1999 Jun 1;5(7):4.
本文引用的文献
1
Risk of adverse gastrointestinal outcomes in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis.服用环氧化酶-2抑制剂或传统非甾体抗炎药患者出现不良胃肠道后果的风险：基于人群的巢式病例对照分析。
BMJ. 2005 Dec 3;331(7528):1310-6. doi: 10.1136/bmj.331.7528.1310.
2
Efficacy, tolerability, and upper gastrointestinal safety of celecoxib for treatment of osteoarthritis and rheumatoid arthritis: systematic review of randomised controlled trials.塞来昔布治疗骨关节炎和类风湿关节炎的疗效、耐受性及上消化道安全性：随机对照试验的系统评价
BMJ. 2002 Sep 21;325(7365):619. doi: 10.1136/bmj.325.7365.619.
3
Efficacy and safety of COX 2 inhibitors.环氧化酶-2抑制剂的疗效与安全性。
BMJ. 2002 Sep 21;325(7365):607-8. doi: 10.1136/bmj.325.7365.607.
4
Are H2 receptor antagonists safe over the counter drugs?H2受体拮抗剂是非处方药吗？它们安全吗？
BMJ. 1994;309(6953):493-4. doi: 10.1136/bmj.309.6953.493.
5
Non-steroidal anti-inflammatory drugs and elderly patients.非甾体抗炎药与老年患者
BMJ. 1995 Apr 1;310(6983):817-8. doi: 10.1136/bmj.310.6983.817.
Zotero 插件